Category archives for: Business

Chairman, President & CEO of Amerisourcebergen Corp (NYSE:ABC), Collis Steven H, sells 20,914 shares worth $2,446,101

According to Amerisourcebergen Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:05 PM, company Chairman, President & CEO, Collis Steven H disclosed selling 20,914 shares at a cost of $116.96. At the time of this transaction (Apr 13), this trade was worth $2,446,101 in […]

Director of Old Republic International Corp (NYSE:ORI), Kovaleski Charles J, buys 250 shares worth $5,818

According to Old Republic International Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 05:49 PM, company Director, Kovaleski Charles J disclosed buying 250 shares at a cost of $23.27. At the time of this transaction (Apr 14), this trade was worth $5,818 in total. […]

SVP, President, APAC of Baxter International Inc (NYSE:BAX), Frye Andrew, sells 10,999 shares worth $932,605

According to Baxter International Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:04 PM, company SVP, President, APAC, Frye Andrew disclosed selling 10,999 shares at a cost of $84.79. At the time of this transaction (Apr 12), this trade was worth $932,605 in total. […]

Director of Evergy, Inc. (NYSE:EVRG), Wilder C John, buys 2,269,447 shares worth $113,177,322

According to Evergy, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 05:27 PM, company Director, Wilder C John disclosed buying 2,269,447 shares at a cost of $49.87. At the time of this transaction (Apr 14), this trade was worth $113,177,322 in total. As of […]

Director of Movado Group Inc (NYSE:MOV), Sadove Stephen I, sells 5,000 shares worth $157,150

According to Movado Group Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:02 PM, company Director, Sadove Stephen I disclosed selling 5,000 shares at a cost of $31.43. At the time of this transaction (Apr 13), this trade was worth $157,150 in total. As […]

10% Owner of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), Cambrian Biopharma Inc, buys 2,000 shares worth $28,000

According to Sensei Biotherapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 05:00 PM, company 10% Owner, Cambrian Biopharma Inc disclosed buying 2,000 shares at a cost of $14.00. At the time of this transaction (Apr 13), this trade was worth $28,000 in total. […]

CHIEF SCIENTIFIC OFFICER of Generation Bio Co. (NASDAQ:GBIO), Stanton Matthew, sells 6,000 shares worth $157,446

According to Generation Bio Co.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:01 PM, company CHIEF SCIENTIFIC OFFICER, Stanton Matthew disclosed selling 6,000 shares at a cost of $26.24. At the time of this transaction (Apr 12), this trade was worth $157,446 in total. […]

10% Owner of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), Novo Holdings A/S, buys 666,666 shares worth $9,999,990

According to Reneo Pharmaceuticals, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:44 PM, company 10% Owner, Novo Holdings A/S disclosed buying 666,666 shares at a cost of $15.00. At the time of this transaction (Apr 13), this trade was worth $9,999,990 in total. […]

Director of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), Bristol James Arthur, sells 14,700 shares worth $644,411

According to Deciphera Pharmaceuticals, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:00 PM, company Director, Bristol James Arthur disclosed selling 14,700 shares at a cost of $43.84. At the time of this transaction (Apr 12), this trade was worth $644,411 in total. As […]

Director of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), Peyer James, buys 2,000 shares worth $28,000

According to Sensei Biotherapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:41 PM, company Director, Peyer James disclosed buying 2,000 shares at a cost of $14.00. At the time of this transaction (Apr 13), this trade was worth $28,000 in total. As of […]

Featured Press Releases

Photo Gallery

Log in